DE:X2S Stock Latest News
Company AnnouncementsSinopharm Accord Q3 profit jumps on modest revenue growth2d ago
Company AnnouncementsSinopharm Group Signs Three-Year IT Services Deal With Controlling Shareholder’s Unit5d ago
Company AnnouncementsSinopharm Group Reports Asset Growth Amid Working Capital Shift6d ago
Company AnnouncementsSinopharm Accord Posts Steady Nine-Month Results but Strong Q3 Profit Rebound1w ago
Company AnnouncementsSinopharm Unit CNCMLtd Posts Higher Q3 Profit but Negative Cash Flow1w ago
Company AnnouncementsSinopharm Board to Review Unaudited Third-Quarter Results1w ago
Company AnnouncementsSinopharm Subsidiary Sinopharm Accord Posts Lower Interim Profit and Negative Cash Flow2M ago
Company AnnouncementsSinopharm Group Posts Slight Profit Decline in 2026 Interim Results2M ago- Company AnnouncementsSinopharm Seeks Shareholder Nod to Renew Diverse Board for Three-Year Term2M ago
Company AnnouncementsSinopharm Divests Controlling Stake in Guorui Pharmaceutical in Connected Deal2M ago
Company AnnouncementsSinopharm Subsidiary Posts Higher Revenue but Lower Profits in First-Half 20262M ago
Company AnnouncementsSinopharm Revamps Board Structure and Committee Roles2M ago- Company AnnouncementsSinopharm Accord Posts Lower First-Half Profit Despite Stable Revenue and Strong Equity Base2M ago
- Company AnnouncementsSinopharm Board Sets August Meeting to Approve Interim Results2M ago
- Company AnnouncementsSinopharm Sets Final 2025 Dividend and Clarifies Withholding Tax for H-Share Investors4M ago
Company AnnouncementsSinopharm Shareholders Approve 2025 Results and Final Dividend at AGM4M agoCompany AnnouncementsSinopharm Sets 2025 AGM to Approve Dividend, Guarantees and Share Issuance Mandate5M ago
